Source: European Archives of Oto-Rhino-Laryngology and Head & Neck. Unidade: FM
Subjects: ANTINEOPLÁSICOS (ADMINISTRAÇÃO E DOSAGEM), NEOPLASIAS DE CABEÇA E PESCOÇO (RADIOGRAFIA;RADIOTERAPIA), CARCINOMA DE CÉLULAS ESCAMOSAS (QUIMIOTERAPIA)
ABNT
CASTRO JUNIOR, Gilberto de et al. High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology and Head & Neck, v. 264, n. 12, p. 1475-1482, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00405-007-0395-9. Acesso em: 05 out. 2024.APA
Castro Junior, G. de, Snitcovsky, M. L., Gebrim, E. M. M. S., Leitão, G. M., Nadalin, W., Ferraz, A. R., & Federico, M. H. H. (2007). High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology and Head & Neck, 264( 12), 1475-1482. doi:10.1007/s00405-007-0395-9NLM
Castro Junior G de, Snitcovsky ML, Gebrim EMMS, Leitão GM, Nadalin W, Ferraz AR, Federico MHH. High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma [Internet]. European Archives of Oto-Rhino-Laryngology and Head & Neck. 2007 ; 264( 12): 1475-1482.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s00405-007-0395-9Vancouver
Castro Junior G de, Snitcovsky ML, Gebrim EMMS, Leitão GM, Nadalin W, Ferraz AR, Federico MHH. High-dose cisplatin concurrent to concentionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma [Internet]. European Archives of Oto-Rhino-Laryngology and Head & Neck. 2007 ; 264( 12): 1475-1482.[citado 2024 out. 05 ] Available from: https://doi.org/10.1007/s00405-007-0395-9